1. Taiwan Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
We Can Medicines Co., Ltd.

We Can Medicines Co., Ltd.

TTPEX:6929
21.25
TWD
-1.30
(-5.76%)
-1.73EPS
1.07BMarket Cap
Nov 06Next Earn
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
83.05
69.86
82.57
78.07
75.23
71.59
70.96
Basic EPS, GAAP
1.33
0.97
2.5
0.37
-1.09
-1.63
-1.73
Free Cash Flow per Basic Share
0.56
2.86
5.59
1.15
4.41
4.54
6.24
Dividend per Share
- -
- -
- -
- -
0.28
- -
- -
Book Value per Share
16.14
17.11
19.79
20.41
24.88
23.26
22.36
Tangible Book Value per Share
15.88
16.88
19.67
20.31
24.73
23.17
22.28
Basic Weighted Avg Shares
32
40
40
40
43
45
45
Sales/Revenue/Turnover
2,667
2,794
3,303
3,123
3,269
3,222
3,207
Operating Margin (%)
1.3
1.09
3.67
0.69
-1.53
-2.1
-2.41
Depreciation Expense
198
214
254
276
309
321
319
Net Income, GAAP
43
39
100
15
-47
-73
-78
Effective Tax Rate (%)
- -
- -
17.4
31.47
- -
- -
- -
Profit Margin (%)
1.6
1.39
3.03
0.47
-1.44
-2.27
-2.43
Working Capital
346
219
254
246
543
502
450
LT Debt
497
717
852
964
1,001
937
856
Total Equity
646
685
792
816
1,116
1,048
1,008
Return on Invested Capital (%)
- -
2.09
5.62
0.82
- -
- -
- -
Return on Capital (%)
- -
3.67
6.73
1.55
- -
- -
- -
Return on Common Equity (%)
- -
5.83
13.56
1.84
-4.88
-6.76
-7.4

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
260
310
256
LT Borrowings
133
131
130
LT Finance Leases
804
791
726
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
45
45
45
Market Capitalization
1,550
1,411
1,071

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,450
1,369
1,347
Cash, Cash Equivalents & STI
286
247
224
Accounts Receivable, Net
193
183
200
Inventories
846
835
839
Total Current Liabilities
948
920
897
Payables & Accruals
- -
- -
- -
ST Debt
260
310
256
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
11.09%
-6.07%
Free Cash Flow
- -
174.93%
6.61%
Net Income, GAAP
- -
-59.99%
55.19%
Sales/Revenue/Turnover
- -
4.15%
-1.45%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
818
824
813
815
3,269
2025
798
817
790
818
3,222
2026
797
803
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.27
-0.08
-0.47
-0.75
-1.09
2025
-0.28
-0.15
-0.58
-0.62
-1.63
2026
-0.21
-0.32
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.28
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Te Lan Wen
Full Time Employees
1,020
Sector
Retail trade
Industry
Drugstore chains
Address
No. 925, Taiwan Avenue Taichung Taiwan
IPO Date
Mar 28, 2024
Website
yourchance.com.tw
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
MedPlus Health Services Ltd. (NSE:MEDPLUS)
Raia Drogasil S.A. (B3:RADL3)
Business
We Can Medicines Co., Ltd. oversees a network of health and beauty retail outlets across Taiwan. The firm supplies a diverse selection of items, encompassing pharmaceuticals, various health-enhancing foods, goods for mothers and infants, and medical apparatus. They market products under their proprietary VITALPLUS line and also feature items from the Sapporo brand. Founded in 1987, the company maintains its primary offices in Taichung, Taiwan. We Can Medicines Co., Ltd. commenced trading on the Taipei Exchange with the ticker 6929 in March 2024. The enterprise operates as a division of Yousheng Medical Technology Co., Ltd.